✦ LIBER ✦

Converting cancer mutations into therapeutic opportunities

✍ Scribed by Tom O'Brien; David Stokoe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer-associated IDH mutations: biomark

✍ Yen, K E; Bittinger, M A; Su, S M; Fantin, V R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 584 KB

Cancer dormancy: Opportunities for new t

✍ Uhr, Jonathan W.; Scheuermann, Richard H.; Street, Nancy E.; Vitetta, Ellen S. 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 649 KB

Angiogenesis in Prostate Cancer: Biology

✍ Brian Nicholson; Greg Schaefer; Dan Theodorescu 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 137 KB

Integrins in cancer: biological implicat

✍ Desgrosellier, Jay S.; Cheresh, David A. 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

Integrins in cancer: biological implicat

✍ Desgrosellier, Jay S.; Cheresh, David A. 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 776 KB

Raf kinases in cancer–roles and therapeu

✍ Maurer, G; Tarkowski, B; Baccarini, M 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 624 KB